Additionally, the presence of proliferative MKI67+ T cells was exclusive to TNBC patients experiencing disease progression after chemotherapy, and their gene expression correlated with lymph node metastases, tumor invasion, and adverse survival outcomes22. Here, MKI67 is linked to neoplasm.